Bioton S.A. Logo

Bioton S.A.

A global manufacturer of recombinant human insulin and diabetes care solutions.

BIO | WAR

Overview

Corporate Details

ISIN(s):
PLBIOTN00029
LEI:
259400I5R1L3OPCGII81
Country:
Poland
Address:
Warszawa Starościńska 5, 02-516 Warszawa

Description

Bioton S.A. is a biotechnology company focused on providing comprehensive solutions for diabetes care. The company's core activity is the development and production of recombinant human insulin, positioning it as a significant commercial manufacturer globally. Its operations cover the full biotechnological process, from DNA research and development to the manufacturing and marketing of finished medicinal products. The product portfolio is centered on various forms of insulin and is complemented by modern automatic injection systems designed to facilitate effective diabetes treatment for patients.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2017-06-23 20:11
Treść uchwał ZWZ BIOTON S.A., które odbyło się w dniu 22.06.2017 r. - Content (…
Polish 117 bytes
2017-06-05 19:09
Wszczęcie postępowania arbitrażowego przeciwko LG Chem, Ltd. - Content (PL)
Polish 2.4 KB
2017-05-30 19:25
Informacje dodatkowe do raportu
Polish 217.4 KB
2017-05-30 19:25
Sprawozdania finansowe (Grupy Kapitałowej BIOTON S.A. i BIOTON S.A.)
Polish 178.8 KB
2017-05-27 18:41
Ogłoszenie o zwołaniu ZWZ BIOTON S.A. na dzień 22.06.2017 (wraz z projektami uc…
Polish 585.0 KB
2017-05-27 18:41
Ogłoszenie o zwołaniu ZWZ BIOTON S.A. na dzień 22.06.2017 r. (wraz z projektami…
Polish 117 bytes
2017-05-16 23:54
Powołanie osoby zarządzającej BIOTON S.A. - Content (PL)
Polish 2.0 KB
2017-05-16 23:53
Podział funkcji w Radzie Nadzorczej BIOTON S.A. - Content (PL)
Polish 1.4 KB
2017-05-16 23:52
Lista akcjonariuszy posiadających co najmniej 5 % liczby głosów na ZWZ BIOTON S…
Polish 276.8 KB
2017-05-16 23:52
Lista akcjonariuszy posiadających co najmniej 5 % liczby głosów na ZWZ BIOTON S…
Polish 117 bytes
2017-05-16 23:52
Odwołanie i powołanie osób nadzorujących BIOTON S.A. - Content (PL)
Polish 4.5 KB
2017-05-16 23:50
Treść uchwał NWZ BIOTON S.A., które odbyło się w dniu 15.05.2017 r.
Polish 309.8 KB
2017-05-16 23:50
Rezygnacja osoby nadzorującej BIOTON S.A. - Content (PL)
Polish 545 bytes
2017-05-16 23:50
Treść uchwał NWZ BIOTON S.A., które odbyło się w dniu 15.05.2017 r. - Content (…
Polish 117 bytes
2017-05-12 20:16
Rezygnacja osoby nadzorującej BIOTON S.A. - Content (PL)
Polish 540 bytes

Automate Your Workflow. Get a real-time feed of all Bioton S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Bioton S.A.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Bioton S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Access Bio, Inc. Logo
Develops and manufactures in vitro diagnostic solutions for infectious diseases.
United States of America
950130
ACHIEVE LIFE SCIENCES, INC. Logo
A late-stage pharmaceutical company developing a treatment for nicotine dependence.
United States of America
ACHV
AC Immune SA Logo
Biopharmaceutical firm developing precision medicine for neurodegenerative diseases.
United States of America
ACIU
Aclaris Therapeutics, Inc. Logo
Clinical-stage biopharmaceutical company developing drugs for immuno-inflammatory diseases.
United States of America
ACRS
Acrivon Therapeutics, Inc. Logo
Clinical-stage biopharma using proteomics to develop precision oncology therapies.
United States of America
ACRV
Acticor Biotech Logo
Develops treatments for thrombotic diseases, focusing on acute ischemic stroke.
France
ALACT
Actinium Pharmaceuticals, Inc. Logo
Clinical-stage company developing targeted radiotherapies for difficult-to-treat cancers.
United States of America
ATNM
ACTUATE THERAPEUTICS, INC. Logo
Clinical-stage biopharma developing therapies for cancers with high unmet needs.
United States of America
ACTU
AcuCort AB Logo
Develops user-friendly drug formulations for severe and acute allergic reactions.
Sweden
ACUC
Acumen Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing targeted therapies for Alzheimer's disease.
United States of America
ABOS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.